Zhongcai Health Beijing Biological Technology Development

Zhongcai Health (Beijing) Biological Technology Development is a specialized biotechnology company and contract research organization (CRO) based in Beijing, China. The company focuses on advanced pharmacokinetic (PK) and pharmacodynamic (PD) modeling, specifically utilizing physiologically based pharmacokinetic (PBPK) and target occupancy (TO) simulations to optimize drug development. Their research expertise covers small molecules and natural products, with a strong emphasis on therapeutic areas such as metabolic diseases, central nervous system disorders, and oncology. Zhongcai Health frequently collaborates with leading academic institutions, including the Beijing University of Chinese Medicine, to provide deep insights into drug-target interactions and binding kinetics. The company's proprietary modeling platforms, such as PBPK-JO and PBPK-DO, are instrumental in predicting clinical outcomes and determining optimal dosing regimens.